Express News | Iteos and GSK Initiate Galaxies Lung-301 Phase 3 Study, Assessing Belrestotug and Dostarlimab in Previously Untreated, Unresectable Locally Advanced / Metastatic Pd-L1 Selected Non-Small Cell Lung Cancer

ReutersJun 17 09:00 ET

J.P. Morgan Maintains ITeos Therapeutics(ITOS.US) With Buy Rating

J.P. Morgan analyst Brian Cheng maintains $ITeos Therapeutics(ITOS.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 31.2% and a total average return of -18.7% over

moomoo NewsJun 5 17:31 ET

We Think ITeos Therapeutics, Inc.'s (NASDAQ:ITOS) CEO Compensation Package Needs To Be Put Under A Microscope

Key Insights iTeos Therapeutics to hold its Annual General Meeting on 11th of June Total pay for CEO Michel Detheux includes US$578.9k salary The total compensation is 38% higher than the average

Simply Wall StJun 5 07:54 ET

10 Health Care Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan

BenzingaMay 28 13:35 ET

ITeos Therapeutics (NASDAQ:ITOS): Harnessing the Power of Immunotherapy

TipRanksMay 14 14:23 ET

Merck Discontinues Testing of Experimental Skin Cancer Combo Therapy

Seeking AlphaMay 13 07:58 ET